Advanced search
Publication Cover
Blood and Lymphatic Cancer: Targets and Therapy Volume 4, 2014 - Issue
Submit an article Journal homepage
84
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use

Gregory P Kaufman1 Department of Internal MedicineCorrespondence[email protected]
,
Kay M Ristow1 Department of Internal Medicine;2 Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Svetomir N Markovic1 Department of Internal Medicine;2 Division of Hematology, Mayo Clinic, Rochester, MN, USA
&
Luis F Porrata1 Department of Internal Medicine;2 Division of Hematology, Mayo Clinic, Rochester, MN, USA
Pages 39-44 | Published online: 23 Jul 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.